Deep learning for differentiating benign from malignant tumors on breast-specific gamma image

Technol Health Care. 2023;31(S1):61-67. doi: 10.3233/THC-236007.

Abstract

Background: Breast diseases are a significant health threat for women. With the fast-growing BSGI data, it is becoming increasingly critical for physicians to accurately diagnose benign as well as malignant breast tumors.

Objective: The purpose of this study is to diagnose benign and malignant breast tumors utilizing the deep learning model, with the input of breast-specific gamma imaging (BSGI).

Methods: A benchmark dataset including 144 patients with benign tumors and 87 patients with malignant tumors was collected and divided into a training dataset and a test dataset according to the ratio of 8:2. The convolutional neural network ResNet18 was employed to develop a new deep learning model. The model proposed was compared with neural network and autoencoder models. Accuracy, specificity, sensitivity and ROC were used to evaluate the performance of different models.

Results: The accuracy, specificity and sensitivity of the model proposed are 99.1%, 98.8% and 99.3% respectively, which achieves the best performance among all methods. Additionally, the Grad-CAM method is used to analyze the interpretability of the diagnostic results based on the deep learning model.

Conclusion: This study demonstrates that the proposed deep learning method could help physicians diagnose benign and malignant breast tumors quickly as well as reliably.

Keywords: Breast-specific gamma imaging (BSGI); breast tumor; convolutional neural network; deep learning.

MeSH terms

  • Breast / diagnostic imaging
  • Breast Neoplasms* / diagnostic imaging
  • Breast Neoplasms* / pathology
  • Deep Learning*
  • Female
  • Humans
  • Mammography / methods
  • Neural Networks, Computer